Somatic mutations in SF3B1 in cancer alter the correct recognition of pre-RNA patterns by the spliceosome due to reduced fidelity of branch-point selection and has recently been found to promote tumor glycolysis in PDAC [7, 13–15]. The gene discussed is SF3B1; the disease is cancer.